Cyclosporin A and Its Analogs Inhibit Hepatitis B Virus Entry Into Cultured Hepatocytes Through Targeting a Membrane Transporter, Sodium Taurocholate Cotransporting Polypeptide (NTCP)
Koichi Watashi(Tokyo University of Science), Takaji Wakita(National Institute of Infectious Diseases), Akihide Ryo(National Institute of Infectious Diseases), Satoko Matsunaga(Daiichi-Sankyo (Japan)), Ann E. Sluder(Massachusetts General Hospital), Senko Tsukuda(National Institute of Infectious Diseases), Masaya Sugiyama(National Center for Global Health and Medicine), Takuji Daito(Neurological Surgery), Shushi Nagamori(Jikei University School of Medicine), Masashi Iwamoto(Rockefeller University), Hiroyuki Kusuhara(The University of Tokyo), Yoshikatsu Kanai(Open Society), Syo Nakajima(National Institute of Infectious Diseases), Yasuhito Tanaka(Kumamoto University), Masashi Mizokami(National Institute of Advanced Industrial Science and Technology), Katyna Borroto–Esoda(Gilead Sciences (United States))
Cited by 259
Related Papers
Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *
|Hepatology|2005|1.5k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
|Gastroenterology|2006|882
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
|Science Translational Medicine|2009|434